The Emmes Company, LLC
UEI NBQCBJ6FXBU4 · MD · SAM.gov record ↗
$72.7M
FY2025 obligations
55
Contract awards
Feb 27, 2015
First action
Sep 30, 2025
Latest action
Obligations by agency
- Department Of Health And Human Services$72.7M
Obligations by NAICS
Monthly obligations
Oct 24
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Sep 25
Contracts ending within 18 months (recompete watch)
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75N95023C00013 ↗ | DATA COORDINATING CENTER (DCC) TO WORK COLLABORATIVELY WITH THE NATIONAL NEUROHIV TISSUE CONSORTIUM (NNTC) CLINICAL SITES FOR NIMH | National Institutes Of Health | 541715 | $2.0M | Aug 7, 2023 | Aug 6, 2026 |
| 75N95023F00004 ↗ | CCC TO 11 - CTN-0145: STANDARD VERSUS HIGH DOSE ED-INITIATED BUPRENORPHINE INDUCTION. POP: 8/28/23 - 8/27/27. | National Institutes Of Health | 541715 | $268K | Aug 28, 2023 | Aug 27, 2026 |
| 75N91024C00024 ↗ | LOGISTICAL AND IT SUPPORT FOR THE NCI CENTRAL INDIVIDUAL REVIEW BOARD (CIRB) | National Institutes Of Health | 541611 | $9.0M | Sep 1, 2024 | Aug 31, 2026 |
| 75N95022C00041 ↗ | NINDS CENTER FOR CLINICAL TRIAL RESOURCES | National Institutes Of Health | 541714 | $1.2M | Sep 30, 2022 | Sep 29, 2026 |
| 75N95022F00003 ↗ | OFFICE-BASED METHADONE VS BUPRENORPHINE TO ADDRESS RETENTION IN MEDICATION FOR OPIOID USE DISORDER (MOUD)-A PRAGMATIC HYBRID EFFECTIVENESS/IMPLEMENTATION TRIAL (CTN-013). 09/28/2022 - 01/31/2027. DSC6. 75N95022F00003 (TO3). | National Institutes Of Health | 541715 | $0 | Sep 28, 2022 | Jan 31, 2027 |
| 75N95022F00004 ↗ | KETAMINE FOR METHAMPHETAMINE USE DISORDER STUDY (CTN-0132). 09/28/2022 - 03/31/2027. DSC6. 75N95022F00004 (TO4). | National Institutes Of Health | 541715 | $501K | Sep 28, 2022 | Mar 31, 2027 |
Largest awards
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75N93021C00012 ↗ | SDCC | National Institutes Of Health | 541713 | $26.7M | Mar 1, 2021 | Feb 28, 2026 |
| 75N91021C00009 ↗ | CLINICAL TRIALS AND INFORMATION MANAGEMENT SUPPORT | National Institutes Of Health | 541611 | $9.2M | Jun 1, 2021 | May 31, 2026 |
| 75N91024C00024 ↗ | LOGISTICAL AND IT SUPPORT FOR THE NCI CENTRAL INDIVIDUAL REVIEW BOARD (CIRB) | National Institutes Of Health | 541611 | $9.0M | Sep 1, 2024 | Aug 31, 2026 |
| HHSN275201700002C ↗ | DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT | National Institutes Of Health | 541711 | $6.0M | Jul 28, 2017 | May 28, 2026 |
| 75N95025F00001 ↗ | TO4. CLINICAL COORDINATING CENTER FOR NIDA'S CLINICAL TRIALS NETWORK. CONTRACT TYPE: IDIQ TASK ORDER. POP: 8/15/24 - 8/14/29 | National Institutes Of Health | 541715 | $4.7M | Jul 16, 2025 | Jul 15, 2026 |
| 75N98022C00001 ↗ | DEVELOPMENT, STATISTICAL DESIGN, MONITORING AND COORDINATION OF VISION CLINICAL TRIALS AND EPIDEMIOLOGY RESEARCH. | National Institutes Of Health | 541715 | $4.5M | Nov 1, 2021 | Oct 31, 2025 |
| 75N95025F00001 ↗ | DSC MANAGEMENT AND SUPPORT. MARCH 1, 2025 TO FEBRUARY 28, 2026. N01DA-22-2253. TASK ORDER NO. 75N95025F00001 (TO25). | National Institutes Of Health | 541715 | $2.3M | Mar 1, 2025 | Feb 28, 2026 |
| 75N93020C00002 ↗ | DATA MANAGEMENT AND DATA WAREHOUSING | National Institutes Of Health | 541511 | $2.0M | Oct 15, 2019 | Oct 14, 2025 |
| 75N95023C00013 ↗ | DATA COORDINATING CENTER (DCC) TO WORK COLLABORATIVELY WITH THE NATIONAL NEUROHIV TISSUE CONSORTIUM (NNTC) CLINICAL SITES FOR NIMH | National Institutes Of Health | 541715 | $2.0M | Aug 7, 2023 | Aug 6, 2026 |
| 75N95025F00002 ↗ | TO5. CLINICAL COORDINATING CENTER FOR NIDA'S CLINICAL TRIALS NETWORK. CONTRACT TYPE: IDIQ TASK ORDER. POP: 8/15/24 - 8/14/29 | National Institutes Of Health | 541715 | $1.7M | Jul 16, 2025 | Mar 31, 2028 |
| 75N95025F00002 ↗ | DATA AND STATISTICAL ANALYSIS FOR GLP-1 AS AN ADJUNCT TO BUPRENORPHINE. MAY 21, 2025 - FEBRUARY 29, 2028. N01DA-22-2253. TASK ORDER NO. 75N95025F00002 (TO26). | National Institutes Of Health | 541715 | $1.4M | May 21, 2025 | Feb 29, 2028 |
| 75N95022C00041 ↗ | NINDS CENTER FOR CLINICAL TRIAL RESOURCES | National Institutes Of Health | 541714 | $1.2M | Sep 30, 2022 | Sep 29, 2026 |
| 75N95022F00002 ↗ | INTEGRATED CARE AND TREATMENT FOR SEVERE INFECTIOUS DISEASES AND SUBSTANCE USE DISORDERS (SUD) AMONG HOSPITALIZED PATIENTS (CTN-0121). 09/28/2022 - 02/07/2026. DSC6. 75N95022F00002 (TO2). | National Institutes Of Health | 541715 | $668K | Sep 28, 2022 | Feb 7, 2026 |
| HHSN26800003 ↗ | THE NATIONAL MYELODYSPLASTIC SYNDROMES (MDS) NATURAL HISTORY STUDY, DATA COORDINATING CENTER (DCC) | National Institutes Of Health | 541712 | $562K | Aug 30, 2016 | Dec 31, 2025 |
| 75N95022F00004 ↗ | KETAMINE FOR METHAMPHETAMINE USE DISORDER STUDY (CTN-0132). 09/28/2022 - 03/31/2027. DSC6. 75N95022F00004 (TO4). | National Institutes Of Health | 541715 | $501K | Sep 28, 2022 | Mar 31, 2027 |
| 75N98022F00001 ↗ | EMMES CORP:1108738 [22-001337] | National Institutes Of Health | 541611 | $496K | Mar 28, 2022 | Mar 24, 2025 |
| 75N92025F00004 ↗ | CLINICAL RESEARCH SUPPORT AND COLLABORATION FOR NHGRI PROTOCOLS | National Institutes Of Health | 541690 | $361K | May 1, 2025 | Apr 30, 2026 |
| 75N94025F00001 ↗ | NICHD:R&D:DATA COORDINATING CENTER FOR THE FOLLOW-UP OF THE SECOND PHASE (COHORT 2) OF THE PRENATAL AND CHILDHOOD MECHANISMS OF HEALTH DISPARITIES OBSERVATIONAL STUDY:NON-SEVERABLE | National Institutes Of Health | 541715 | $320K | Aug 15, 2025 | Mar 31, 2026 |
| 75N95023F00004 ↗ | CCC TO 11 - CTN-0145: STANDARD VERSUS HIGH DOSE ED-INITIATED BUPRENORPHINE INDUCTION. POP: 8/28/23 - 8/27/27. | National Institutes Of Health | 541715 | $268K | Aug 28, 2023 | Aug 27, 2026 |
| 75N92025F00003 ↗ | CLINICAL RESEARCH SUPPORT AND COLLABORATION FOR NHGRI PROTOCOLS | National Institutes Of Health | 541690 | $144K | Mar 1, 2025 | Feb 28, 2026 |
| 75N92025F00006 ↗ | CLINICAL RESEARCH SUPPORT AND COLLABORATION FOR NHGRI PROTOCOLS - STATISTICAL EXPERTISE FOR PROTEUS (TASK AREA 4) | National Institutes Of Health | 541690 | $117K | Jun 3, 2025 | Jun 2, 2026 |
| 75N92025F00007 ↗ | STATISTICAL EXPERTISE FOR SBSRB (TASK AREA 4) | National Institutes Of Health | 541690 | $111K | Jul 1, 2025 | Jun 30, 2026 |
| 75N92025F00002 ↗ | CLINICAL RESEARCH SUPPORT AND COLLABORATION FOR NHGRI PROTOCOLS | National Institutes Of Health | 541690 | $53K | Mar 1, 2025 | Feb 28, 2026 |
| 75N92024F00006 ↗ | CLINICAL RESEARCH SUPPORT AND COLLABORATION FOR NHGRI PROTOCOLS, TASK AREA 4--STATISTICAL EXPERTISE | National Institutes Of Health | 541690 | $50K | Jul 1, 2024 | Jun 30, 2025 |
| 75N92025F00009 ↗ | CLINICAL RESEARCH SUPPORT AND COLLABORATION FOR NHGRI PROTOCOLS: TASK AREA 2 - REGULATORY SUPPORT FOR IND AND IDE SUBMISSIONS | National Institutes Of Health | 541690 | $42K | Jul 1, 2025 | Jun 30, 2026 |